Cytokinetics Heart Drug’s Trial Data Look Competitive With BMS Med Camzyos Healthcare Resources By On Dec 27, 2023 0 Share Cytokinetics drug aficamten met the main goal of a pivotal test in obstructive hypertrophic cardiomyopathy. If approved, the daily pill would compete against a Bristol Myers Squibb drug projected to become a blockbuster seller. 0 Share